Don't get left behind! The modernized ClinicalTrials.gov is coming. Check it out now.
Say goodbye to ClinicalTrials.gov!
The new site is coming soon - go to the modernized ClinicalTrials.gov
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Finnish Genetic Study for Arrhythmic Events (FinGesture)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02075866
Recruitment Status : Unknown
Verified March 2014 by University of Oulu.
Recruitment status was:  Recruiting
First Posted : March 3, 2014
Last Update Posted : March 4, 2014
Sponsor:
Information provided by (Responsible Party):
University of Oulu

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Finnish Genetic Study for Arrhythmic Events (FinGesture is a prospective case-control study assessing the characteristics and genetic background of consecutive series of autopsy verified out-of-hospital victims of SCD vs. survivors of an acute coronary event in a specific geographical area in northern Finland.

Condition or disease
Sudden Cardiac Death Acute Coronary Event

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 8000 participants
Observational Model: Case-Control
Time Perspective: Prospective
Target Follow-Up Duration: 1 Day
Official Title: Finnish Genetic Study for Arrhythmic Events
Study Start Date : January 1998
Estimated Primary Completion Date : December 2017
Estimated Study Completion Date : December 2017

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. sudden cardiac death [ Time Frame: 20 years ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Consecutive victims of sudden cardiac death verified by medicolegal autopsy (cases).

Acute coronary event patients admitted to the Oulu University Hospital who survived to be discharged from the hospital (controls).

Criteria

Inclusion Criteria:

  • Sudden cardiac death verified by medicolegal autopsy (cases)
  • Acute coronary event (increased troponin levels/ECG markers of ischemia/angina pectoris; two out of three criteria) (controls).

Exclusion Criteria:

  • Sudden death due to other causes (cases).
  • Acute coronary event patients who died during hospitalization (controls).
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02075866


Contacts
Layout table for location contacts
Contact: Eeva Hookana, PhD 35883154464 eeva.hookana@oulu.fi
Contact: Juhani Junttila, MD, PhD 358505444367 juhani.junttila@oulu.fi

Locations
Layout table for location information
Finland
Oulu University Hospital Recruiting
Oulu, Finland, 90014
Contact: Eeva Hookana, PhD    35883154464    eeva.hookana@oulu.fi   
Sponsors and Collaborators
University of Oulu
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Additional Information:

Layout table for additonal information
Responsible Party: University of Oulu
ClinicalTrials.gov Identifier: NCT02075866    
Other Study ID Numbers: Uoulu-FinGesture
First Posted: March 3, 2014    Key Record Dates
Last Update Posted: March 4, 2014
Last Verified: March 2014
Additional relevant MeSH terms:
Layout table for MeSH terms
Death, Sudden, Cardiac
Death
Pathologic Processes
Heart Arrest
 Heart Diseases
Cardiovascular Diseases
Death, Sudden